KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) Equity Average (2016 - 2025)

Zimmer Biomet Holdings has reported Equity Average over the past 17 years, most recently at $12.7 billion for Q4 2025.

  • Quarterly results put Equity Average at $12.7 billion for Q4 2025, up 2.46% from a year ago — trailing twelve months through Dec 2025 was $12.7 billion (up 2.46% YoY), and the annual figure for FY2025 was $12.6 billion, up 0.87%.
  • Equity Average for Q4 2025 was $12.7 billion at Zimmer Biomet Holdings, up from $12.7 billion in the prior quarter.
  • Over the last five years, Equity Average for ZBH hit a ceiling of $12.7 billion in Q4 2025 and a floor of $12.1 billion in Q2 2022.
  • Median Equity Average over the past 5 years was $12.5 billion (2023), compared with a mean of $12.4 billion.
  • Biggest five-year swings in Equity Average: increased 7.55% in 2021 and later decreased 4.34% in 2022.
  • Zimmer Biomet Holdings' Equity Average stood at $12.7 billion in 2021, then decreased by 4.34% to $12.1 billion in 2022, then grew by 3.0% to $12.5 billion in 2023, then dropped by 0.59% to $12.4 billion in 2024, then grew by 2.46% to $12.7 billion in 2025.
  • The last three reported values for Equity Average were $12.7 billion (Q4 2025), $12.7 billion (Q3 2025), and $12.5 billion (Q2 2025) per Business Quant data.